Intraoperative Parathyroid Hormone Monitoring Criteria in Primary Hyperparathyroidism: A Network Meta-Analysis of Diagnostic Test Accuracy.

IF 6 1区 医学 Q1 OTORHINOLARYNGOLOGY JAMA otolaryngology-- head & neck surgery Pub Date : 2024-12-26 DOI:10.1001/jamaoto.2024.4453
Phillip Staibano, Michael Au, Han Zhang, Sheila Yu, Winnie Liu, Jesse D Pasternak, Xing Xing, Carolyn D Seib, Lisa Orloff, Nhu-Tram Nguyen, Michael K Gupta, Eric Monteiro, Sameer Parpia, Tyler McKechnie, Alex Thabane, J E M Ted Young, Mohit Bhandari
{"title":"Intraoperative Parathyroid Hormone Monitoring Criteria in Primary Hyperparathyroidism: A Network Meta-Analysis of Diagnostic Test Accuracy.","authors":"Phillip Staibano, Michael Au, Han Zhang, Sheila Yu, Winnie Liu, Jesse D Pasternak, Xing Xing, Carolyn D Seib, Lisa Orloff, Nhu-Tram Nguyen, Michael K Gupta, Eric Monteiro, Sameer Parpia, Tyler McKechnie, Alex Thabane, J E M Ted Young, Mohit Bhandari","doi":"10.1001/jamaoto.2024.4453","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Intraoperative parathyroid hormone (IOPTH) monitoring is recommended by the American Association of Endocrine Surgeons for use during parathyroidectomy for patients with primary hyperparathyroidism (PHPT), but there is no clinician consensus regarding the IOPTH monitoring criteria that optimize diagnostic accuracy.</p><p><strong>Objective: </strong>To evaluate and rank the diagnostic properties of IOPTH monitoring criteria used during surgery for patients with PHPT.</p><p><strong>Data sources: </strong>A bayesian diagnostic test accuracy network meta-analysis (DTA-NMA) was performed, in which peer-reviewed citations from January 1, 1990, to July 22, 2023, were searched for in MEDLINE, Embase, Web of Science, CENTRAL, and CINAHL.</p><p><strong>Study selection: </strong>All full-text study designs that evaluated any IOPTH monitoring criteria as a diagnostic test were included in this meta-analysis. Any studies evaluating adult patients diagnosed with PHPT undergoing parathyroidectomy were also included. The reference standard used in this study was normalization of calcium and/or parathyroid hormone levels within 1 year of surgery.</p><p><strong>Data extraction and synthesis: </strong>This DTA-NMA was reported in accordance with the applicable Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines. Two reviewers evaluated all abstracts and full-text articles using a piloted extraction form. A third author resolved any conflicts. There are no published Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) resources for DTA-NMA. The following conventional monitoring criteria were included: Halle, Miami, Rome, Vienna, and PTH normalization, and the following modified criteria were included: Miami and PTH normalization, modified Miami, and modified Vienna. A bayesian hierarchical DTA-NMA model with corresponding 95% credible intervals (CrIs) was used to describe the pooled diagnostic characteristics of the evaluated IOPTH monitoring criteria.</p><p><strong>Main outcomes and measures: </strong>Main outcomes included pooled diagnostic test properties, including sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio.</p><p><strong>Results: </strong>A total of 72 studies, which included 19 072 patients, met the inclusion criteria. Sixty-nine studies (95.8%) investigated classic PHPT. In PHPT, the Miami criteria were investigated most often and had the best diagnostic properties (diagnostic odds ratio, 60.00 [95% CrI, 32.00-145.00]) when compared to other conventional criteria. Moreover, the modified Miami criteria, which measures a postexcision IOPTH level 15 minutes or more postexcision of all hyperfunctioning parathyroid tissue, were the overall best criteria (diagnostic odds ratio, 79.71 [95% CrI, 22.46-816.67]). There was a low risk of study bias and no publication bias.</p><p><strong>Conclusions and relevance: </strong>The results of this meta-analysis suggest that surgeons should use the modified Miami criteria when performing IOPTH-guided surgery for patients with PHPT because these criteria optimize intraoperative diagnostic accuracy by minimizing unnecessary neck exploration and revision surgery rates.</p>","PeriodicalId":14632,"journal":{"name":"JAMA otolaryngology-- head & neck surgery","volume":" ","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA otolaryngology-- head & neck surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamaoto.2024.4453","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Intraoperative parathyroid hormone (IOPTH) monitoring is recommended by the American Association of Endocrine Surgeons for use during parathyroidectomy for patients with primary hyperparathyroidism (PHPT), but there is no clinician consensus regarding the IOPTH monitoring criteria that optimize diagnostic accuracy.

Objective: To evaluate and rank the diagnostic properties of IOPTH monitoring criteria used during surgery for patients with PHPT.

Data sources: A bayesian diagnostic test accuracy network meta-analysis (DTA-NMA) was performed, in which peer-reviewed citations from January 1, 1990, to July 22, 2023, were searched for in MEDLINE, Embase, Web of Science, CENTRAL, and CINAHL.

Study selection: All full-text study designs that evaluated any IOPTH monitoring criteria as a diagnostic test were included in this meta-analysis. Any studies evaluating adult patients diagnosed with PHPT undergoing parathyroidectomy were also included. The reference standard used in this study was normalization of calcium and/or parathyroid hormone levels within 1 year of surgery.

Data extraction and synthesis: This DTA-NMA was reported in accordance with the applicable Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines. Two reviewers evaluated all abstracts and full-text articles using a piloted extraction form. A third author resolved any conflicts. There are no published Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) resources for DTA-NMA. The following conventional monitoring criteria were included: Halle, Miami, Rome, Vienna, and PTH normalization, and the following modified criteria were included: Miami and PTH normalization, modified Miami, and modified Vienna. A bayesian hierarchical DTA-NMA model with corresponding 95% credible intervals (CrIs) was used to describe the pooled diagnostic characteristics of the evaluated IOPTH monitoring criteria.

Main outcomes and measures: Main outcomes included pooled diagnostic test properties, including sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio.

Results: A total of 72 studies, which included 19 072 patients, met the inclusion criteria. Sixty-nine studies (95.8%) investigated classic PHPT. In PHPT, the Miami criteria were investigated most often and had the best diagnostic properties (diagnostic odds ratio, 60.00 [95% CrI, 32.00-145.00]) when compared to other conventional criteria. Moreover, the modified Miami criteria, which measures a postexcision IOPTH level 15 minutes or more postexcision of all hyperfunctioning parathyroid tissue, were the overall best criteria (diagnostic odds ratio, 79.71 [95% CrI, 22.46-816.67]). There was a low risk of study bias and no publication bias.

Conclusions and relevance: The results of this meta-analysis suggest that surgeons should use the modified Miami criteria when performing IOPTH-guided surgery for patients with PHPT because these criteria optimize intraoperative diagnostic accuracy by minimizing unnecessary neck exploration and revision surgery rates.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
原发性甲状旁腺功能亢进术中甲状旁腺激素监测标准:诊断测试准确性的网络meta分析。
重要性:美国内分泌外科医生协会推荐在原发性甲状旁腺功能亢进(PHPT)患者进行甲状旁腺切除术时使用术中甲状旁腺激素(IOPTH)监测,但临床医生对优化诊断准确性的IOPTH监测标准尚无共识。目的:对PHPT患者手术中使用的IOPTH监测标准的诊断特性进行评价和排序。数据来源:在MEDLINE、Embase、Web of Science、CENTRAL和CINAHL中检索1990年1月1日至2023年7月22日的同行评审引文,进行贝叶斯诊断测试准确性网络元分析(DTA-NMA)。研究选择:所有评估任何IOPTH监测标准作为诊断测试的全文研究设计都包括在本荟萃分析中。任何评估诊断为PHPT并行甲状旁腺切除术的成年患者的研究也被纳入。本研究使用的参考标准是手术后1年内钙和/或甲状旁腺激素水平的正常化。数据提取和综合:本DTA-NMA按照适用的系统评价和荟萃分析(PRISMA)报告指南的首选报告项目进行报告。两名审稿人评估了所有的摘要和全文文章使用试点提取形式。第三位作者解决了任何冲突。DTA-NMA没有公开的推荐、评估、发展和评估分级(GRADE)资源。包括以下常规监测标准:Halle、Miami、Rome、Vienna和PTH正常化;包括以下修改标准:Miami和PTH正常化、修改Miami和修改Vienna。采用具有相应95%可信区间(CrIs)的贝叶斯分层DTA-NMA模型来描述所评估的IOPTH监测标准的汇总诊断特征。主要结局和测量指标:主要结局包括合并诊断试验特性,包括敏感性、特异性、阳性似然比、阴性似然比和诊断优势比。结果:共有72项研究,19 072例患者符合纳入标准。69项研究(95.8%)调查经典PHPT。在PHPT中,与其他常规标准相比,Miami标准被研究得最多,并且具有最好的诊断特性(诊断优势比为60.00 [95% CrI, 32.00-145.00])。此外,改良后的Miami标准是总体最佳标准(诊断优势比为79.71 [95% CrI, 22.46-816.67]),该标准测量切除后所有功能异常的甲状旁腺组织在切除后15分钟或更长时间内的IOPTH水平。研究偏倚风险低,无发表偏倚。结论和相关性:本荟萃分析的结果表明,外科医生在对PHPT患者进行iopth引导手术时应使用改良的Miami标准,因为这些标准通过减少不必要的颈部探查和翻修手术率来优化术中诊断的准确性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.10
自引率
5.10%
发文量
230
期刊介绍: JAMA Otolaryngology–Head & Neck Surgery is a globally recognized and peer-reviewed medical journal dedicated to providing up-to-date information on diseases affecting the head and neck. It originated in 1925 as Archives of Otolaryngology and currently serves as the official publication for the American Head and Neck Society. As part of the prestigious JAMA Network, a collection of reputable general medical and specialty publications, it ensures the highest standards of research and expertise. Physicians and scientists worldwide rely on JAMA Otolaryngology–Head & Neck Surgery for invaluable insights in this specialized field.
期刊最新文献
Back to the Workforce-An Important Marker of Survivorship. Concerns Regarding Mouth Closure and Airflow in Obstructive Sleep Apnea. Concerns Regarding Mouth Closure and Airflow in Obstructive Sleep Apnea-Reply. Errors in Table and Figures. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1